Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
The COVID-19 pandemic caused by SARS-CoV-2 is a continuous challenge worldwide, and there is an urgent need to map the landscape of immunogenic and immunodominant epitopes recognized by CD8 + T cells. Here, we analyze samples from 31 patients with COVID-19 for CD8 + T cell recognition of 500 peptide-HLA class I complexes, restricted by 10 common HLA alleles. We identify 18 CD8 + T cell recognized SARS-CoV-2 epitopes, including an epitope with immunodominant features derived from ORF1ab and restricted by HLA-A*01:01. In-depth characterization of SARS-CoV-2-specific CD8 + T cell responses of patients with acute critical and severe disease reveals high expression of NKG2A, lack of cytokine production and a gene expression profile inhibiting T cell re-activation and migration while sustaining survival. SARS-CoV-2-specific CD8 + T cell responses are detectable up to 5 months after recovery from critical and severe disease, and these responses convert from dysfunctional effector to functional memory CD8 + T cells during convalescence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Identification of SARS-CoV-2-specific CD8 T cell responses. a Overview of the selected SARS-CoV-2 epitopes derived from the different SARS-CoV-2 ORFs for each of the 5 HLA-A and 5 HLA-B alleles included in this study. b Representative flow cytometric plots of two different SARS-CoV-2-specific CD8 T cell responses detected in patient COVID-153. Magnitude of the response (percentage of double-positive pHLA+ cells [green] of total CD8+ cells [gray]) is indicated. Representative gating strategy is provided in Supplementary Fig. 1. c Heatmap of detected SARS-CoV-2-specific CD8 T cell responses (n = 35) including information about CD8 T cell-recognized SARS-CoV-2 epitopes (n = 18) and their viral protein origin, the magnitude of the response (pHLA+ cells of total CD8+ cells), and HLA coverage as well as the disease status for each COVID-19 patient (n = 31) and healthy donor (n = 7). Confirmation of identified responses was done for patients COVID-004, 087, 096, 121, 127, 143, and 153 with similar results. d Overview of the magnitude, target epitope origin, and number of detected SARS-CoV-2-specific CD8 T cell responses (n = 35) across the included HLA alleles. Source data are provided as a Source data file. e Difference in the magnitude of SARS-CoV-2-specific CD8 T cell responses targeting epitopes derived from ORF1ab (n = 20) compared to CD8 T cell responses targeting epitopes derived from all other SARS-CoV-2 proteins (n = 15) combined. All detected responses are included. Box plots indicate the median (line), 25th and 75th percentile (box), min and max (whiskers), and all data points (single circles). Statistical significance was tested with a two-tailed Mann–Whitney U test, P = 0.0309. Source data are provided as a Source data file. f Number of SARS-CoV-2 epitopes (n = 18) that were recognized by CD8 T cells across different HLA alleles. g Bar graphs illustrating the contribution of each ORF to the SARS-CoV-2 proteome (left) in comparison to the fraction of the selected epitopes per ORF based on our predictions (middle) and the contribution of each ORF to the CD8 T cell-recognized epitopes (right). ORF open reading frame, S spike, N nucleoprotein, M membrane, pHLA peptide human leukocyte antigen, PTD PTDNYITTY, TTD TTDPSFLGRY.](https://figures.cochat.ai/paper-figures/9ee7e5ada7cc4a3e90672a4943ec2ec5/identification-and-characterization-of-a-sars-cov-2-specific-cd8-t-cell-response-figure-1.jpg)



![Fig. 5 Characterization of SARS-CoV-2-specific CD8 T cells during acute disease and convalescence. a Representative dot plots of the TTD-specific CD8 T cell response detected in patient COVID-143. Magnitude of the response (percentage of double-positive pHLA+ cells [green] of total CD8+ cells [gray]) is indicated. Representative gating strategy is shown in Supplementary Fig. 5. b Magnitude of SARS-CoV-2-specific CD8 T cell responses (n = 6) detected in COVID-19 patients (n = 3). Source data are provided as a Source data file. c Representative gating strategy used to quantify the fraction of CD95+, CXCR3+, HLA-DR+, CD45RA+, and CCR7+ TTD-specific CD8 T cells in COVID-096. Gates were set based on bulk CD8 T cells (representative gating strategy is shown in Supplementary Fig. 5). d Fraction of CD95+, CXCR3+, HLA-DR+, CD45RA+, and CCR7+ SARS-CoV-2-specific CD8 T cell responses (n = 6) detected in COVID-19 patients (n = 3). Individual points are annotated according to CD8 T cell specificity for individual patients as shown in Fig. 5b. Statistical significance was tested with a two-tailed Wilcoxon signed-rank test, P = 0.0312. Source data are provided as a Source data file. e Representative histogram of the expression levels (MFI) of PD-1 on SARS-CoV-2-specific CD8 T cells in COVID-096. f Expression levels (MFI) of PD-1 on SARS-CoV-2-specific CD8 T cell responses (n = 6) detected in COVID-19 patients (n = 3). Individual points are annotated according to CD8 T cell specificity for individual patients as shown in Fig. 5b. Statistical significance was tested with a two-tailed Wilcoxon signed-rank test, P = 0.0312. Source data are provided as a Source data file. g Representative gating used to assess the expression of IFNγ, TNF, IL-2, and IL-17 in CD8 T cells in patient COVID-143 after 12-h peptide stimulation with TTD. Percentages of cytokine-producing cells are indicated. Full gating strategy is shown in Supplementary Fig. 3a–c. h Functionality of CD8 T cells (n = 2) after 12-h peptide stimulation with TTD. DMSO control-subtracted percentages are shown. Two independent experiments were performed for patient COVID-143 with similar results. AD acute disease, CON convalescence, TTD TTDPSFLGRY, PTD PTDNYITTY, DTD DTDFVNEFY, pHLA peptide human leukocyte antigen. * P < 0.05.](https://figures.cochat.ai/paper-figures/aac47383b3934352b0470ddb4308ac93/identification-and-characterization-of-a-sars-cov-2-specific-cd8-t-cell-response-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using HLA class I and II predicted peptide “megapools,” circulating SARS-CoV-2-specific CD8+ and CD4+ T cells were identified in COVID-19 acute, mild and convalescent patients [110, 118-125].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [123]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“18 CD8+ T cell recognized SARS-CoV-2 epitopes, including an epitope with immunodominant features derived from ORF1ab and restricted by HLA-A*01:01 were idenfied”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [123]
The cited source says what the claim attributes to it.
In the citing paper
“indicating the possibility to develop a vaccine based upon CD8+ T cells response against Ags different from the spike protein [123].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [123]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 78 · Cited by 111
Metadata
- Authors
- Gangaev, A., Ketelaars, S. L. C., Isaeva, O. I., Patiwael, S., Dopler, A., Hoefakker, K., De Biasi, S., Gibellini, L., Mussini, C., Guaraldi, G., Girardis, M., Ormeno, C. M. P. T., Hekking, P. J. M., Lardy, N. M., Toebes, M., Balderas, R., Schumacher, T. N., Ovaa, H., Cossarizza, A., & Kvistborg, P.
- Affiliations
- The Netherlands Cancer Institute (NL)
- University of Modena and Reggio Emilia (IT)
- Leiden University Medical Center (NL)
- Sanquin (NL)
- BD Biosciences (United States) (US)
- Corresponding author
- Kvistborg, Pia
- ORCID
- Venue
- Nature Communications
- Published
- 2021-05-10
- Volume
- 12
- Issue
- 1
- Pages
- 2593-2593
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC8110804
- OpenAlex
- W3160342471
- Cited by
- 111
- References
- 78
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 11 · 2023: 29 · 2022: 40 · 2021: 14
- FWCI
- 7.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Leiden Repository (Leiden University) (submittedVersion, cc-by)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- International Society for Advancement of Cytometry
- Ministero della Salute (COVID-2020–12371808, 2020-2021, 2015-2020)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV-2, COVID-19 pandemic, CD8+ T cells, T cell epitopes, immunodominant epitopes, HLA-A*01:01, ORF1ab, NKG2A, T cell exhaustion, memory T cells, convalescence, severe COVID-19
- MeSH terms
- COVID-19, SARS-CoV-2, Adult, Aged, Aged, 80 and over, Alleles, Female, Humans, Immunologic Memory, Lymphocyte Activation, Male, Middle Aged, Viral Proteins, Histocompatibility Antigens Class I, Immunodominant Epitopes, CD8-Positive T-Lymphocytes, Epitopes, T-Lymphocyte, Polyproteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features. https://app.cochat.ai/papers/10.1038/s41467-021-22811-y
- The paper
- Gangaev, A., Ketelaars, S. L. C., Isaeva, O. I., Patiwael, S., Dopler, A., Hoefakker, K., De Biasi, S., Gibellini, L., Mussini, C., Guaraldi, G., Girardis, M., Ormeno, C. M. P. T., Hekking, P. J. M., Lardy, N. M., Toebes, M., Balderas, R., Schumacher, T. N., Ovaa, H., Cossarizza, A., & Kvistborg, P. (2021). Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features. Nature Communications. https://doi.org/10.1038/s41467-021-22811-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.